These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34349088)
1. Crocetin Exerts a Cardio-protective Effect on Mice with Coxsackievirus B3-induced Acute Viral Myocarditis. Qin L; Liu H; Wang J; Wang W; Zhang L J Oleo Sci; 2021; 70(8):1115-1124. PubMed ID: 34349088 [TBL] [Abstract][Full Text] [Related]
2. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis. Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183 [TBL] [Abstract][Full Text] [Related]
3. Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3. Li-Sha G; Jing-Lin Z; Guang-Yi C; Li L; De-Pu Z; Yue-Chun L Sci Rep; 2015 Oct; 5():15895. PubMed ID: 26507386 [TBL] [Abstract][Full Text] [Related]
4. [Protective effect of hydrogen sulfide on mice with experimental viral myocarditis and its mechanism]. Qian H; Liu L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):708-12. PubMed ID: 25001934 [TBL] [Abstract][Full Text] [Related]
5. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis]. Qian H; Liu L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor. Yu XH; Li SJ; Chen RZ; Yang YZ; Zhang P Chin Med J (Engl); 2012 Jan; 125(1):50-5. PubMed ID: 22340465 [TBL] [Abstract][Full Text] [Related]
7. Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice. Xue Y; Chen M; Chen Q; Huang T; Fan Q; Lin F; Ke J; Chen F Virol J; 2021 Nov; 18(1):220. PubMed ID: 34775963 [TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888 [TBL] [Abstract][Full Text] [Related]
10. Antiviral and myocyte protective effects of IL-28A in coxsackievirus B3-induced myocarditis. Wang S; Huang X; Zhang J; Huang C Braz J Infect Dis; 2015; 19(2):132-40. PubMed ID: 25528576 [TBL] [Abstract][Full Text] [Related]
11. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy. Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. Zhang YY; Li JN; Xia HH; Zhang SL; Zhong J; Wu YY; Miao SK; Zhou LM Life Sci; 2013 Jul; 92(24-26):1186-94. PubMed ID: 23702425 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L; He X; Gao B; Xiong S J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170 [TBL] [Abstract][Full Text] [Related]
14. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice. Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196 [TBL] [Abstract][Full Text] [Related]
15. Role of neutrophils in CVB3 infection and viral myocarditis. Rivadeneyra L; Charó N; Kviatcovsky D; de la Barrera S; Gómez RM; Schattner M J Mol Cell Cardiol; 2018 Dec; 125():149-161. PubMed ID: 30393107 [TBL] [Abstract][Full Text] [Related]
16. The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3. Fengqin L; Yulin W; Xiaoxin Z; Youpeng J; Yan C; Qing-qing W; Hong C; Jia S; Lei H J Ethnopharmacol; 2010 Feb; 127(2):221-8. PubMed ID: 19932162 [TBL] [Abstract][Full Text] [Related]
17. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice. Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552 [TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647 [TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice. Zhang H; Song Y; Zhang Z Am J Med Sci; 2012 Sep; 344(3):206-10. PubMed ID: 22197982 [TBL] [Abstract][Full Text] [Related]
20. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis. Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]